Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
PLoS One ; 10(11): e0142778, 2015.
Article de Anglais | MEDLINE | ID: mdl-26562658

RÉSUMÉ

The international response to Haiti's ongoing cholera outbreak has been multifaceted, including health education efforts by community health workers and the distribution of free water treatment products. Artibonite Department was the first region affected by the outbreak. Numerous organizations have been involved in cholera response efforts in Haiti with many focusing on efforts to improve water, sanitation, and hygiene (WASH). Multiple types of water treatment products have been distributed, creating the potential for confusion over correct dosage and water treatment methods. We utilized qualitative methods in Artibonite to determine the population's response to WASH messages, use and acceptability of water treatment products, and water treatment and sanitation knowledge, attitudes and practices at the household level. We conducted eighteen focus group discussions (FGDs): 17 FGDs were held with community members (nine among females, eight among males); one FGD was held with community health workers. Health messages related to WASH were well-retained, with reported improvements in hand-washing. Community health workers were identified as valued sources of health information. Most participants noted a paucity of water-treatment products. Sanitation, specifically the construction of latrines, was the most commonly identified need. Lack of funds was the primary reason given for not constructing a latrine. The construction and maintenance of potable water and sanitation services is needed to ensure a sustainable change.


Sujet(s)
Choléra/épidémiologie , Communication sur la santé , Éducation pour la santé , Amélioration du niveau sanitaire , Purification de l'eau , Femelle , Haïti/épidémiologie , Communication sur la santé/méthodes , Éducation pour la santé/méthodes , Humains , Mâle , Amélioration du niveau sanitaire/méthodes , Vibrio cholerae/isolement et purification , Purification de l'eau/méthodes
2.
Malar J ; 8: 85, 2009 Apr 28.
Article de Anglais | MEDLINE | ID: mdl-19400953

RÉSUMÉ

BACKGROUND: National malaria control programmes must deal with the complex process of changing national malaria treatment guidelines, often without guidance on the process of change. Selecting a replacement drug is only one issue in this process. There is a paucity of literature describing successful malaria treatment policy changes to help guide control programs through this process. OBJECTIVES: To understand the wider context in which national malaria treatment guidelines were formulated in a specific country (Peru). METHODS: Using qualitative methods (individual and focus group interviews, stakeholder analysis and a review of documents), a retrospective analysis of the process of change in Peru's anti-malarial treatment policy from the early 1990's to 2003 was completed. RESULTS: The decision to change Peru's policies resulted from increasing levels of anti-malarial drug resistance, as well as complaints from providers that the drugs were no longer working. The context of the change occurred in a time in which Peru was changing national governments, which created extreme challenges in moving the change process forward. Peru utilized a number of key strategies successfully to ensure that policy change would occur. This included a) having the process directed by a group who shared a common interest in malaria and who had long-established social and professional networks among themselves, b) engaging in collaborative teamwork among nationals and between nationals and international collaborators, c) respect for and inclusion of district-level staff in all phases of the process, d) reliance on high levels of technical and scientific knowledge, e) use of standardized protocols to collect data, and f) transparency. CONCLUSION: Although not perfectly or fully implemented by 2003, the change in malaria treatment policy in Peru occurred very quickly, as compared to other countries. They identified a problem, collected the data necessary to justify the change, utilized political will to their favor, approved the policy, and moved to improve malaria control in their country. As such, they offer an excellent example for other countries as they contemplate or embark on policy changes.


Sujet(s)
Antipaludiques/usage thérapeutique , Prise de décision , Résistance aux substances , Politique de santé/histoire , Paludisme à Plasmodium falciparum/traitement médicamenteux , Paludisme/traitement médicamenteux , Comportement coopératif , Collecte de données , Personnel de santé/économie , Personnel de santé/enseignement et éducation , Main-d'oeuvre en santé , Histoire du 20ème siècle , Histoire du 21ème siècle , Humains , Paludisme/prévention et contrôle , Paludisme à Plasmodium falciparum/prévention et contrôle , Pérou , Recherche qualitative , Études rétrospectives
3.
Health Policy Plan ; 19(6): 356-70, 2004 Nov.
Article de Anglais | MEDLINE | ID: mdl-15459161

RÉSUMÉ

Widespread resistance of Plasmodium falciparum parasites to commonly used antimalarials, such as chloroquine, has resulted in many endemic countries considering changing their malaria treatment policy. Identifying and understanding the key influences that affect decision-making, and factors that facilitate or undermine policy implementation, is critical for improving the policy process and guiding resource allocation during this process. A historical review of archival documents from Malawi and data obtained from in-depth policy studies in four countries (Tanzania, South Africa, Kenya and Peru) that have changed malaria treatment policy provides important lessons about decision-making, the policy cycle and complex policy environment, while specifically identifying strategies successfully employed to facilitate policy-making and implementation. Findings from these country-level studies indicate that the process of malaria drug policy review should be institutionalized in endemic countries and based on systematically collected data. Key stakeholders need to be identified early and engaged in the process, while improved communication is needed on all levels. Although malaria drug policy change is often perceived to be a daunting task, using these and other proven strategies should assist endemic countries to tackle this challenge in a systematic fashion that ensures the development and implementation of the rational malaria drug policy.


Sujet(s)
Antipaludiques/usage thérapeutique , Politique de santé , Paludisme à Plasmodium falciparum/traitement médicamenteux , Types de pratiques des médecins/législation et jurisprudence , Afrique , Antipaludiques/effets indésirables , Antipaludiques/économie , Prise de décision , Coûts des soins de santé , Humains , Paludisme à Plasmodium falciparum/économie , Pérou , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE